Clinical trials: Binge Eating Disorder (BED)
Binge-Eating Disorder
Low Intensity Focused Ultrasound for Binge Eating Disorder
This study is a prospective, single-center, single-arm early feasibility study, to establish safety and tolerability of LIFU for neuromodulation in patients with Binge Eating Disorder (BED)
- Trial name
- NCT06485687
- Testing
- LIFU Neuromodulation
- Where
- United States
- Volunteers
- 15 people
- Sponsor
- Ali Rezai
Binge Eating Disorder, Obesity
Hormone Release and Stomach Disturbances in People With Binge Eating Disorder
This study will determine whether the disturbances in cholecystokinin release and gastric emptying that occur in people with binge eating disorder are similar to those that occur in people with bulimia nervosa.
- Conditions
- Binge Eating Disorder, Obesity, Eating Disorders
- Trial name
- NCT00307190
- Where
- United States
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- New York State Psychiatric Institute
Binge-Eating Disorder
Light Therapy and Binge Eating Disorder Treatment (BED Light Study)
Binge Eating Disorder (BED) is the most widespread food behavior disorder, with prevalence three times higher than anorexia. Its pathophysiology remains poorly understood and the investigators have few therapeutic options.
- Trial name
- NCT03094260
- Testing
- High intensity bright light therapy, Low intensity light therapy
- Where
- France
- Volunteers
- 11 people
- Sponsor
- Hospices Civils de Lyon
Binge Eating Disorder, Bulimia Nervosa
Healthy Approach to weIght Management and Food in Eating Disorders (HAPIFED)
The investigators have developed a new integrated therapy, namely a Healthy Approach to weIght management and Food in Eating Disorders (HAPIFED).
- Conditions
- Binge Eating Disorder, Bulimia Nervosa, Eating Disorder
- Trial name
- HAPIFED (NCT02464345)
- Testing
- HAPIFED, CBT-E
- Where
- Brazil
- Volunteers
- 98 people
- Sponsor
- Federal University of São Paulo
Binge-Eating Disorder
Transcranial Magnetic Stimulation (TMS) in Binge Eating Disorder (BED)
This study evaluates de efficacy of 5Hz repetitive Transcranial Magnetic Stimulation (rTMS) applied on the left dorsolateral prefrontal cortex in patients with binge eating disorder.
- Trial name
- TMS&BED (NCT03540641)
- Testing
- MagVenture MagPro R30
- Where
- Mexico
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- Universidad Autonoma de Queretaro
Bulimia Nervosa, Binge-Eating Disorder
Pilot Study on the Validity of the Metacognitive Hub Model of Craving in Bulimia Nervosa (BN) and Binge Eating Disorders (BED)
Craving is defined as an irrepressible urge to consume certain products and represents one of the key factors in severe substance use disorders, as illustrated by its recent inclusion as a diagnostic criterion in the most recent…
- Trial name
- MetaBou (NCT05879679)
- Testing
- Food craving induction
- Where
- 3 sites in Canada, France
- Volunteers
- 60 people
- Sponsor
- Laval University
Binge Eating Disorder
Clinical Trial on Binge Eating Disorder, Treatment With Naloxone Spray
The investigators are studying a new treatment for one subtype of obesity. Obesity is not a disease. It is a symptom of several different diseases.
- Trial name
- BED (NCT01567670)
- Testing
- Naloxone
- Volunteers
- 138 people, healthy volunteers welcome
- Sponsor
- Lightlake Sinclair Ltd.
Binge Eating Disorder
Comparing a Group-based Guided Self-help Approach to Pure Self-help for the Treatment of BED
Binge eating disorder (BED) is the most common eating disorder in adults, affecting 2.8% of the population. The disorder is characterized by recurrent episodes of binge eating which are not followed by inappropriate compensatory…
- Trial name
- NCT04432311
- Testing
- Binge Focused Therapy (BFT), CBT Unguided Self Help (CBT USH)
- Where
- Canada
- Volunteers
- 164 people
- Sponsor
- Nova Scotia Health Authority
Eating Disorders, Intermittent Fasting
Effect of Fasting and Calorie-Restricted Diets on Dopamine and Serotonin Levels Among Obese Women With BED and FA
Obesity presents a substantial economic burden in Jordan. Binge eating disorder (BED) and food addiction (FA) are the most common eating disorders associated with obesity.
- Conditions
- Eating Disorders, Intermittent Fasting, Obesity
- Trial name
- NCT04873648
- Testing
- caloric reduced -intermitted fasting diet, Daily calorie restriction, Control group
- Where
- Jordan
- Volunteers
- 100 people
- Sponsor
- University of Jordan
Bulimia Nervosa (BN), Binge Eating Disorder (BED)
Improving Patient Outcome in Group Therapy for Eating Disorders
The current trial aims to investigate the impact of continuous feedback on dropout and outcome in group therapy. The hypothesis is that continuous feedback to patient and therapist on treatment progress and alliance will 1)…
- Conditions
- Bulimia Nervosa (BN), Binge Eating Disorder (BED), Eating Disorder Not Otherwise Specified (EDNOS)
- Trial name
- F-EAT (NCT01693237)
- Testing
- Group psychotherapy, Group psychotherapy with feedback
- Where
- Denmark
- Volunteers
- 159 people
- Sponsor
- Marianne Lau, MD, DSci.
Eating Disorders
Effectiveness of Binge Eating Disorder Treatments
This study will evaluate the long-term effectiveness of interpersonal psychotherapy, behavioral weight loss interventions, and guided self help treatments in treating binge eating disorder (BED).
- Trial name
- NCT00060762
- Testing
- Interpersonal Therapy, Behavioral Weight Loss Treatment, Guided Self Help
- Where
- 3 sites in United States
- Volunteers
- 205 people
- Sponsor
- Stanford University
Bulimia Nervosa, Binge-Eating Disorder
Pre-therapeutic Validation of the Virtual Reality-based Exposure Scenario for CBT "ReVBED" for the Induction of Food Craving in Patients With Bulimia and Binge Eating Disorder (BED)
Food craving is a major therapeutic issue in Eating Disorders with binge eating: the Bulimia Nervosa and the Binge Eating Disorder (BED).
- Trial name
- RevBED (NCT05385653)
- Testing
- experimentation of the virtual reality "RevBED"
- Where
- France
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
Binge Eating Disorder
Open Label Extension in Adults With Binge Eating Disorder (BED)
To evaluate the safety and tolerability of SPD489 administered as a daily morning dose (50 or 70mg) in the treatment of moderate to severe binge eating disorder (BED) in adults
- Trial name
- NCT01657019
- Testing
- Lisdexamfetamine dimesylate
- Where
- 89 sites in United States, Germany and 1 more
- Volunteers
- 604 people
- Sponsor
- Shire
Binge-Eating Disorder
A Study to Assess the Long-term Safety and Efficacy of Solriamfetol in Subjects With Binge Eating Disorder
This is a Phase 3, multi-center, open-label and randomized withdrawal study to evaluate the long-term safety and efficacy of solriamfetol in the treatment of binge eating disorder (BED) in adults.
- Trial name
- NCT06878976
- Testing
- Solriamfetol
- Where
- 33 sites in United States
- Volunteers
- 236 people
- Sponsor
- Axsome Therapeutics, Inc.
Binge Eating Disorder
Video-based Guided Self Help Dialectical Behavior Therapy for Binge Eating Disorder
Dialectical Behavior Therapy (DBT) is an effective treatment for eating disorders, showing promising remission rates for Binge Eating Disorder (BED) in both standard and guided self-help formats.
- Trial name
- VIDEO-DBT-GSH (NCT07327203)
- Testing
- Experimental: Video-based DBTgsh for BED, Traditional DBTgsh for BED (text-based model)
- Where
- Brazil
- Volunteers
- 82 people
- Sponsor
- University of Sao Paulo General Hospital
Binge-Eating Disorder
Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol
ENGAGE (Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol) is a Phase 3, randomized, double-blind, placebo-controlled, multicenter trial to assess the efficacy and safety of solriamfetol…
- Trial name
- ENGAGE (NCT06413433)
- Testing
- Solriamfetol 150 mg, Solriamfetol 300 mg
- Where
- 45 sites in United States
- Volunteers
- 450 people
- Sponsor
- Axsome Therapeutics, Inc.
Binge Eating Disorder
Lisdexamfetamine in Binge Eating Disorder (BED): fMRI Effects
The purpose of this study is to explore the effect of Lisdexamfetamine on Prefrontal Brain Dysfunction in Binge Eating Disorder
- Trial name
- NCT02659488
- Testing
- Lisdexamfetamine
- Where
- United States
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Lindner Center of HOPE
Diabetes Mellitus, Type 2, Binge-Eating Disorder
Type 2 Diabetes and Binge Eating Disorder (BED)
The goal of this research project is to improve the treatment of individuals living with both type 2 diabetes (T2D) and Binge Eating Disorder (BED).
- Trial name
- NCT06325670
- Testing
- BED treatment, Waitlist
- Where
- Denmark
- Volunteers
- 34 people
- Sponsor
- Odense University Hospital
Binge-Eating Disorder, Emotion Regulation
Profiling the Dynamic of Binge Eating Disorder (PRODY-BED)
The goal of this observational study is to explore if different and specific profiles can be identified in adults with binge eating disorder (BED) depending on their additional eating pathology, emotion regulation and executive…
- Conditions
- Binge-Eating Disorder, Emotion Regulation, Executive Dysfunction, Eating Behavior
- Trial name
- PRODY-BED (NCT05726721)
- Testing
- Treatment as usual, Psychotherapy
- Where
- 3 sites in Denmark
- Volunteers
- 180 people
- Sponsor
- Aarhus University Hospital
Binge Eating Disorder
Phentermine/Topiramate Extended Release in Binge Eating Disorder (BED)
The goal of this project is to evaluate the effectiveness and tolerability of the novel weight management medication PHEN/TPM ER (Qsymia®)along with nutritional and lifestyle modification counseling in the treatment of binge…
- Trial name
- NCT02659475
- Testing
- PHEN/TPM ER (Qsymia®)
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- Lindner Center of HOPE